• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微创表面活性剂给药是必要的、“仅仅”有益的还是只是一种潮流?

Is Less Invasive Surfactant Administration Necessary or "Only" Helpful or Just a Fashion?

作者信息

Lista Gianluca, Bresesti Ilia, Fabbri Laura

机构信息

Division of Neonatology, "V.Buzzi" Children's Hospital, Asst Fatebenefratelli Sacco, Milan, Italy.

Global Clinical Development-Neonatology, Chiesi Farmaceutici S.p.A, Parma, Italy.

出版信息

Am J Perinatol. 2018 May;35(6):530-533. doi: 10.1055/s-0038-1637759. Epub 2018 Apr 25.

DOI:10.1055/s-0038-1637759
PMID:29694989
Abstract

In the 1990s, the most relevant pillars in the treatment of neonatal respiratory distress syndrome (RDS) have been improvements in ventilation strategies, the introduction of exogenous surfactant replacement therapy, and the use of antenatal steroids. Lately, in addition to the standard INSURE (INtubation-SURfactant administration-Extubation) method to administer surfactant, a new technique has been gaining increasing popularity. It is the so-called less invasive surfactant administration (LISA) method, which has shown promising results in preventing bronchopulmonary dysplasia development and in reducing mortality in preterm neonates. The rationale behind this technique is to avoid positive pressure ventilation and the endotracheal tube, being surfactant delivered through a thin catheter while the neonate is maintained on continuous positive airway pressure. Given the paucity of large-scale randomized trials on LISA method to prove its effects on short- and long-term outcomes, some questions still remain unanswered. Then, uncertainty regarding the feasibility of this maneuver needs to be better clarified before gaining wide acceptance in routine clinical practice. In our report, we aim at hypothesizing the main mechanisms behind the efficacy of LISA, considering it as a single maneuver in a comprehensive approach for RDS management in the delivery room.

摘要

20世纪90年代,新生儿呼吸窘迫综合征(RDS)治疗中最关键的支柱包括通气策略的改进、外源性表面活性剂替代疗法的引入以及产前类固醇的使用。最近,除了标准的INSURE(插管-表面活性剂给药-拔管)表面活性剂给药方法外,一种新技术越来越受欢迎。这就是所谓的微创表面活性剂给药(LISA)方法,它在预防支气管肺发育不良和降低早产儿死亡率方面显示出了令人鼓舞的结果。该技术背后的基本原理是避免正压通气和气管插管,在新生儿维持持续气道正压时通过细导管输送表面活性剂。鉴于缺乏关于LISA方法对短期和长期结局影响的大规模随机试验,一些问题仍未得到解答。因此,在常规临床实践中广泛接受之前,需要更好地阐明这种操作的可行性方面的不确定性。在我们的报告中,我们旨在推测LISA疗效背后的主要机制,将其视为产房RDS综合管理方法中的单一操作。

相似文献

1
Is Less Invasive Surfactant Administration Necessary or "Only" Helpful or Just a Fashion?微创表面活性剂给药是必要的、“仅仅”有益的还是只是一种潮流?
Am J Perinatol. 2018 May;35(6):530-533. doi: 10.1055/s-0038-1637759. Epub 2018 Apr 25.
2
Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.经鼻给予肺表面活性物质与气管内给予肺表面活性物质后行小潮气量通气治疗中国呼吸窘迫综合征早产儿的随机对照试验研究方案
Trials. 2020 Jun 11;21(1):516. doi: 10.1186/s13063-020-04390-3.
3
Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis.在患有呼吸窘迫综合征的早产儿中,与插管给药相比,采用侵入性较小的表面活性剂给药方式:一项系统评价和荟萃分析。
Arch Dis Child Fetal Neonatal Ed. 2017 Jan;102(1):F17-F23. doi: 10.1136/archdischild-2015-310299. Epub 2016 Nov 15.
4
Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis.对自主呼吸的早产儿进行表面活性剂滴注:一项系统评价和荟萃分析。
Eur J Pediatr. 2016 Dec;175(12):1933-1942. doi: 10.1007/s00431-016-2789-4. Epub 2016 Sep 27.
5
The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.表面活性剂给药技术(肺内滴注法与气管插管-肺表面活性物质给药法)对早产儿呼吸窘迫综合征治疗结局的影响。
Dev Period Med. 2019;23(3):163-171. doi: 10.34763/devperiodmed.20192303.163171.
6
Novel Surfactant Administration Techniques: Will They Change Outcome?新型表面活性剂给药技术:会改变结局吗?
Neonatology. 2019;115(4):411-422. doi: 10.1159/000497328. Epub 2019 Apr 11.
7
Surfactant administration methods for premature newborns: LISA vs. INSURE comparative analysis.表面活性物质给药方法用于早产儿:LISA 与 INSURE 比较分析。
J Neonatal Perinatal Med. 2024;17(2):233-239. doi: 10.3233/NPM-230194.
8
Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome.早产儿呼吸窘迫综合征患者中应用 less invasive beractant 治疗的 3 年围产期结局。
J Matern Fetal Neonatal Med. 2020 Aug;33(16):2704-2710. doi: 10.1080/14767058.2018.1557633. Epub 2019 Jan 7.
9
Minimally invasive surfactant therapy with a gastric tube is as effective as the intubation, surfactant, and extubation technique in preterm babies.在早产儿中,采用胃管进行微创表面活性剂治疗与插管、注入表面活性剂和拔管技术的效果相同。
Acta Paediatr. 2014 Jun;103(6):e229-33. doi: 10.1111/apa.12611. Epub 2014 Mar 15.
10
Less Invasive Surfactant Administration: A Viewpoint.微创表面活性剂给药:观点。
Am J Perinatol. 2024 Jan;41(2):211-227. doi: 10.1055/a-2001-9139. Epub 2022 Dec 20.

引用本文的文献

1
A Quality Improvement Project to Standardize Surfactant Delivery in the Era of Noninvasive Ventilation.一项在无创通气时代规范表面活性剂给药的质量改进项目。
Pediatr Qual Saf. 2020 Jun 26;5(4):e311. doi: 10.1097/pq9.0000000000000311. eCollection 2020 Jul-Aug.
2
Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.经鼻给予肺表面活性物质与气管内给予肺表面活性物质后行小潮气量通气治疗中国呼吸窘迫综合征早产儿的随机对照试验研究方案
Trials. 2020 Jun 11;21(1):516. doi: 10.1186/s13063-020-04390-3.
3
Effects of less invasive surfactant administration (LISA) via a gastric tube on the treatment of respiratory distress syndrome in premature infants aged 32 to 36 weeks.
经胃管给予微创表面活性剂(LISA)对32至36周早产儿呼吸窘迫综合征的治疗效果。
Medicine (Baltimore). 2020 Feb;99(9):e19216. doi: 10.1097/MD.0000000000019216.
4
Minimally Invasive Surfactant Therapy Using a 2.0 mm Uncuffed Endotracheal Tube as the Conduit: An Easily Adaptable Technique.使用2.0毫米无套囊气管内导管作为通道的微创表面活性剂治疗:一种易于应用的技术。
Cureus. 2019 Aug 19;11(8):e5428. doi: 10.7759/cureus.5428.
5
Cerebral oxygenation associated with INSURE versus LISA procedures in surfactant-deficient newborn piglet RDS model.在表面活性物质缺乏的新生猪 RDS 模型中,与 INSURE 与 LISA 操作相关的脑氧合。
Pediatr Pulmonol. 2019 May;54(5):644-654. doi: 10.1002/ppul.24277. Epub 2019 Feb 18.